Trial
NCT02068625
Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
—
Condition
Retinal Detachment
Intervention
Rasagiline
Why stopped
Persisting recruitment difficulties
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-20